Robert J Adelman's Net Worth

$458 Million

Estimate Recalculated Feb 16, 2024 06:26PM EST

Who is Robert J Adelman?

Robert J Adelman has an estimated net worth of $458 Million. This is based on reported shares across multiple companies, which include Volcano Corp, Checkmate Pharmaceuticals, Inc., ARYx Therapeutics, Inc., RayzeBio, Inc., CRYOCOR INC, Ventyx Biosciences, Inc., ALX ONCOLOGY HOLDINGS INC, Akero Therapeutics, Inc., Metacrine, Inc., IMPEL NEUROPHARMA INC, Elevation Oncology, Inc., and PRECISION BIOSCIENCES INC.

SEC CIK

Robert J Adelman's CIK is 0001329161

Past Insider Trading and Trends

2020 was Robert J Adelman's most active year for acquiring shares with 9 total transactions. Robert J Adelman's most active month to acquire stocks was the month of May. 2020 was Robert J Adelman's most active year for disposing of shares, totalling 35 transactions. Robert J Adelman's most active month to dispose stocks was the month of March. 2020 saw Robert J Adelman paying a total of $22,197,000.00 for 14,705,641 shares, this is the most they've acquired in one year. In 2020 Robert J Adelman cashed out on 35,754,223 shares for a total of $20,743,395.94, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Checkmate Pharmaceuticals, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.75%
-131.65K
$10.45
-$1,375,564.42
2.16M
May 13 - May 16
Form 4
-6.57%
-160.90K
$10.39
-$1,671,823.84
2.29M
May 10 - May 12
Form 4
-3.42%
-86.68K
$10.37
-$898,920.56
2.45M
May 5 - May 9
Form 4
-9.65%
-270.68K
$10.38
-$2,809,332.35
2.54M
May 2 - May 4
Form 4
-6.34%
-190.03K
$10.38
-$1,972,578.78
2.81M
Apr 27 - Apr 29
Form 4
-4.15%
-129.78K
$10.39
-$1,347,796.50
3M
Apr 22 - Apr 26
Form 4
-14.91%
-547.73K
$10.41
-$5,700,491.17
3.13M
Apr 19 - Apr 21
Form 4
3.67M
$15.00
3.67M
Aug 11
Form 3
0
0
No matching records found

RayzeBio, Inc. (RYZB) Snapshot price: $62.125

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
5.16M
5.16M
Sep 19
Form 3
0
0
No matching records found

Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Jun 9
Form 4
4M
$16.00
4M
Oct 25
Form 3
0
0
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.535

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-3.70%
-116.47K
$34.40
-$4,006,536.85
3.03M
Jul 1 - Jul 6
Form 4
-1.44%
-45.95K
$23.76
-$1,091,607.66
3.15M
Mar 4 - Mar 6
Form 4
-0.68%
-21.80K
$22.63
-$493,310.23
3.2M
Feb 28 - Mar 3
Form 4
-0.18%
-5.90K
$22.80
-$134,635.10
3.23M
Feb 25 - Feb 27
Form 4
-0.15%
-10.03K
$27.07
-$271,399.19
6.46M
Feb 10 - Feb 12
Form 4
-0.19%
-6.10K
$27.03
-$164,954.76
3.23M
Feb 6
Form 4
-2.48%
-82.34K
$25.77
-$2,121,726.32
3.24M
Feb 4 - Feb 5
Form 4
-12.95%
-494.00K
$20.23
-$9,993,620.00
3.32M
Jan 13
Form 4
-0.41%
-15.68K
$19.86
-$311,354.63
3.82M
Jan 8
Form 4
-1.88%
-73.22K
$19.86
-$1,454,529.98
3.83M
Jan 6 - Jan 7
Form 4
-0.90%
-35.50K
$19.71
-$699,721.20
3.91M
Jan 2 - Jan 3
Form 4
-0.36%
-14.32K
$23.96
-$343,258.90
3.94M
Dec 31
Form 4
3.95M
$16.00
3.95M
Jun 24
Form 3
0
0
No matching records found

IMPEL NEUROPHARMA INC (IMPL) Snapshot price: $0.05

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
2.76M
$15.00
2.76M
Apr 27
Form 4
0
0
Apr 22
Form 3
0
0
No matching records found